Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions

Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions

US Patent 10751334 · Granted Aug 25, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of use for treating aberrant inflammation in peri-ocula2025
Compositions and methods of use for treating aberrant inflammation in peri-ocula2023
Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in 2019
Nitric oxide donating prostamides2012
Prostaglandin derivatives2010
Prostaglandin EP4 antagonists2009
Prostaglandin EP4 antagonist2007
Prostaglandin D2 antagonist2007
Method for imparting artificial tan to human skin2006
Prostamide receptor antagonists2006
Thromboxane ligands without blood clotting side effects2006
EP4 agonists as agents for lowering intraocular pressure2005